Atlas Trials

Study of VTD in Waldenstrom's Macroglobulinemia

Clinical trial NCT03335098 · UNKNOWN

Trial details

NCT number
NCT03335098
Sponsor
Seoul National University Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Waldenstrom MacroglobulinemiaLymphoplasmacytic Lymphoma
Start date
2016-11-21
Primary completion
2020-12-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.